Search

The ability to perceive spatial environments and locate oneself during navigation is crucial for the survival of animals. Mounting evidence suggests a role of the medial prefrontal cortex (mPFC) in spatially related behaviors. However, the properties of mPFC spatial encoding and how it is influenced by animal behavior are poorly defined. Here, we train the mice to perform 3 tasks differing in working memory and reward-seeking: a delayed non-match to place (DNMTP) task, a passive alternation (PA) task, and a free-running task. Single-unit recording in the mPFC shows that although individual mPFC neurons exhibit spatially selective firing, they do not reliably represent the animal location. The population activity of mPFC neurons predicts the animal location. Notably, the population coding of animal locations by the mPFC is modulated by animal behavior in that the coding accuracy is higher in tasks involved in working memory and reward-seeking. This study reveals an approach whereby the mPFC encodes spatial positions and the behavioral variables affecting it.

Mutations in KRAS, NRAS, and BRAF (RAS/BRAF) genes are the main predictive biomarkers for the response to anti-EGFR monoclonal antibodies (MAbs) targeted therapy in metastatic colorectal cancer (mCRC). This retrospective study aimed to report the mutational status prevalence of these genes, explore their possible associations with clinicopathological features, and build and validate a predictive model. To achieve these objectives, 500 mCRC Mexican patients were screened for clinically relevant mutations in RAS/BRAF genes. Fifty-two percent of these specimens harbored clinically relevant mutations in at least one screened gene. Among these, 86% had a mutation in KRAS, 7% in NRAS, 6% in BRAF, and 2% in both NRAS and BRAF. Only tumor location in the proximal colon exhibited a significant correlation with KRAS and BRAF mutational status (p-value = 0.0414 and 0.0065, respectively). Further t-SNE analyses were made to 191 specimens to reveal patterns among patients with clinical parameters and KRAS mutational status. Then, directed by the results from classical statistical tests and t-SNE analysis, neural network models utilized entity embeddings to learn patterns and build predictive models using a minimal number of trainable parameters. This study could be the first step in the prediction for RAS/BRAF mutational status from tumoral features and could lead the way to a more detailed and more diverse dataset that could benefit from machine learning methods.